Arcturus Therapeutics Holdings Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 12,403 | 0.1% | 2,026,588 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 35,879 | 0.3% | 1,947,835 | 9/30/2025 |
| 2025 Q2 | 8/11/2025 | 23,793 | 0.2% | 1,830,203 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 20,378 | 0.3% | 1,926,084 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 34,941 | 0.4% | 2,065,050 | 12/31/2024 |
| 2024 Q3 | 11/7/2024 | 53,692 | 0.6% | 2,315,294 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 37,967 | 0.4% | 1,563,065 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 42,980 | 0.4% | 1,276,519 | 3/31/2024 |
| 2023 Q4 | 2/8/2024 | 41,587 | 0.4% | 1,320,652 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 35,423 | 0.4% | 1,388,574 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 40,251 | 0.4% | 1,404,932 | 6/30/2023 |
| 2023 Q1 | 5/3/2023 | 32,968 | 0.4% | 1,420,401 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 24,562 | 0.4% | 1,449,060 | 12/31/2022 |
| 2022 Q2 | 8/4/2022 | 17,952 | 0.2% | 1,436,194 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 37,856 | 0.3% | 1,402,078 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 47,783 | 0.3% | 1,357,472 | 12/31/2021 |
| 2021 Q3 | 11/9/2021 | 62,492 | 0.3% | 1,358,532 | 9/30/2021 |
| 2021 Q2 | 8/9/2021 | 41,185 | 0.2% | 1,214,901 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 13,043 | 0.1% | 315,812 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 12,046 | 0.1% | 277,686 | 12/31/2020 |
| 2020 Q3 | 11/2/2020 | 5,627 | 0.0% | 131,170 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 6,559 | 0.1% | 143,487 | 6/30/2020 |
| 2020 Q1 | 4/30/2020 | 3,466 | 0.1% | 255,066 | 3/31/2020 |
| 2019 Q4 | 2/6/2020 | 3,050 | 0.0% | 280,548 | 12/31/2019 |